Publications du service de microbiologie-infectiologie du CHUM

Description

2024

1. Alessandrini, J., Cox, J., de Pokomandy, A., Hart, T. A., Grace, D., Grennan, T., Moore, D., Lambert, G., Chambers, C., Deeks, S. L., Grewal, R., Lachowsky, N. J., Sauvageau, C., Tan, D. H. S., Coutlee, F., & Burchell, A. N. (2024). Prevalence of Oral Human Papillomavirus Infection Among Urban Gay, Bisexual, and Other Men Who Have Sex With Men in Canada, 2017-2019. J Infect Dis. https://doi.org/10.1093/infdis/jiae345
2. Al-Soneidar, W. A., Harper, S., Coutlee, F., Gheit, T., Tommasino, M., & Nicolau, B. (2024). Prevalence of Alpha, Beta, and Gamma Human Papillomaviruses in Patients With Head and Neck Cancer and Noncancer Controls and Relation to Behavioral Factors. J Infect Dis, 229(4), 1088-1096. https://doi.org/10.1093/infdis/jiad335
3. Ametepe, E. S. A., Andriamanoha, N., Andrianomanana, F. R., Point, F., Mangahasimbola, R. T., Dyachenko, A., Hall, M., Gamana, T. M., Knoblauch, A. M., Razafindrasoa, Y. Y., Nimalan, A., Behr, M., Durand, M., Johri, M., Iqbal, Z., Rakotoarivelo, A. R., Randremanana, R. V., Rakotosamimanana, N., & Lapierre, S. G. (2024). Whole genome sequencing of M. tuberculosis for disease control in high-burden settings: study protocol for a cluster randomized controlled trial evaluating different community-wide intervention strategies in rural Madagascar. Trials, 25(1), 717. https://doi.org/10.1186/s13063-024-08537-4
4. Arthur, A. W., El-Zein, M., Burchell, A. N., Tellier, P. P., Coutlee, F., & Franco, E. L. (2024). Detection and Clearance of Type-Specific and Phylogenetically Related Genital Human Papillomavirus Infections in Young Women in New Heterosexual Relationships. J Infect Dis, 229(3), 691-706. https://doi.org/10.1093/infdis/jiad450
5. Arthur, A. W., El-Zein, M., Burchell, A. N., Tellier, P. P., Coutlee, F., & Franco, E. L. (2024). Epidemiology of genital human papillomavirus infections in sequential male sex partners of young females. Clin Microbiol Infect, 30(2), 247-253. https://doi.org/10.1016/j.cmi.2023.11.009
6. Baldassarre, L., Quach-Thanh, C., Mouajou Feujio, V., Tadount, F., Deyirmendjian, C., Lefebvre, M. A., Thampi, N., Schneider, O., Fabri-Karam, I., O’Donnell, S., Okeny-Owere, J., Audy, N., & Desmarais, N. (2024). Incidence and risk factors for recurrent Clostridioides difficile infection in pediatric at-risk groups in selected Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) hospitals. Infect Control Hosp Epidemiol, 45(2), 182-187. https://doi.org/10.1017/ice.2023.174
7. Benlarbi, M., Richard, J., Bourassa, C., Tolbert, W. D., Chartrand-Lefebvre, C., Gendron-Lepage, G., Sylla, M., El-Far, M., Messier-Peet, M., Guertin, C., Turcotte, I., Fromentin, R., Verly, M. M., Prevost, J., Clark, A., Mothes, W., Kaufmann, D. E., Maldarelli, F., Chomont, N., . . . Finzi, A. (2024). Plasma Human Immunodeficiency Virus 1 Soluble Glycoprotein 120 Association With Correlates of Immune Dysfunction and Inflammation in Antiretroviral Therapy-Treated Individuals With Undetectable Viremia. J Infect Dis, 229(3), 763-774. https://doi.org/10.1093/infdis/jiad503
8. Benoit, P., Brazer, N., de Lorenzi-Tognon, M., Kelly, E., Servellita, V., Oseguera, M., Nguyen, J., Tang, J., Omura, C., Streithorst, J., Hillberg, M., Ingebrigtsen, D., Zorn, K., Wilson, M. R., Blicharz, T., Wong, A. P., O’Donovan, B., Murray, B., Miller, S., & Chiu, C. Y. (2024). Seven-year performance of a clinical metagenomic next-generation sequencing test for diagnosis of central nervous system infections. Nat Med. https://doi.org/10.1038/s41591-024-03275-1
9. Benoit, P., Wang, S., Wang, C., Chakravarti, A., Villalba, J. A., Ali, I. K. M., Roy, S., Sapp, S. G. H., Reagan-Steiner, S., Nelson, K., Cayrol, R., Luong, M.-L., Grand’Maison, S., & Desjardins, M. (2024). Brainstorm: A case of granulomatous encephalitis. Journal of the Association of Medical Microbiology and Infectious Disease Canada, 9(2), 113-120. https://doi.org/10.3138/jammi-2023-0036
10. Boncheva, I., Poudrier, J., & Falcone, E. L. (2024). Role of the intestinal microbiota in host defense against respiratory viral infections. Curr Opin Virol, 66, 101410. https://doi.org/10.1016/j.coviro.2024.101410
11. Boutin, C. A., Durocher, F., Beauchemin, S., Ziegler, D., Abou Chakra, C. N., & Dufresne, S. F. (2024). Breakthrough Invasive Fungal Infections in Patients With High-Risk Hematological Disorders Receiving Voriconazole and Posaconazole Prophylaxis: A Systematic Review. Clin Infect Dis, 79(1), 151-160. https://doi.org/10.1093/cid/ciae203
12. Boutin, C. A., & Luong, M. L. (2024). Update on therapeutic approaches for invasive fungal infections in adults. Ther Adv Infect Dis, 11, 20499361231224980. https://doi.org/10.1177/20499361231224980
13. Brenner, B. G., Ibanescu, R. I., Oliveira, M., Margaillan, G., Lebouche, B., Thomas, R., Baril, J. G., Lorgeoux, R. P., Roger, M., Routy, J. P., & The Montreal Primary Hiv Infection Phi Cohort Study, G. (2024). Phylogenetic Network Analyses Reveal the Influence of Transmission Clustering on the Spread of HIV Drug Resistance in Quebec from 2002 to 2022. Viruses, 16(8). https://doi.org/10.3390/v16081230
14. Bu, S., Royston, L., Mabanga, T., Berini, C. A., Tremblay, C., Lebouche, B., Cox, J., Costiniuk, C. T., Durand, M., Isnard, S., & Routy, J. P. (2024). Proteomics validate circulating GDF-15 as an independent biomarker for COVID-19 severity. Front Immunol, 15, 1377126. https://doi.org/10.3389/fimmu.2024.1377126
15. RyPTIC Consortium. (2024). Quantitative drug susceptibility testing for Mycobacterium tuberculosis using unassembled sequencing data and machine learning. PLoS Comput Biol, 20(8), e1012260. https://doi.org/10.1371/journal.pcbi.1012260
16. RyPTIC Consortium. (2024). Quantitative measurement of antibiotic resistance in Mycobacterium tuberculosis reveals genetic determinants of resistance and susceptibility in a target gene approach. Nat Commun, 15(1), 488. https://doi.org/10.1038/s41467-023-44325-5
17. Chawla, S., Kaida, A., Brouillette, M. J., Kleiner, B., Dubuc, D., Skerritt, L., Burchell, A. N., Rouleau, D., Loutfy, M., de Pokomandy, A., & team, C. r. (2024). Mental health service use and shortages among a cohort of women living with HIV in Canada. BMC Health Serv Res, 24(1), 923. https://doi.org/10.1186/s12913-024-11396-z
18. Cloutier Charette, W., Rabodoarivelo, M. S., Point, F., Knoblauch, A. M., Andrianomanana, F. R., Hall, M. B., Iqbal, Z., Supply, P., Martin, A., Rakotosamimanana, N., & Grandjean Lapierre, S. (2024). Concordance of targeted and whole genome sequencing for Mycobacterium tuberculosis genotypic drug susceptibility testing. Diagn Microbiol Infect Dis, 109(2), 116249. https://doi.org/10.1016/j.diagmicrobio.2024.116249
19. Colas, S., Marie, B., Milhe-Poutingon, M., Lot, M. C., Boullemant, A., Fortin, C., & Le Faucheur, S. (2024). Meta-metabolomic responses of river biofilms to cobalt exposure and use of dose-response model trends as an indicator of effects. J Hazard Mater, 470, 134099. https://doi.org/10.1016/j.jhazmat.2024.134099
20. Colas, S., Marie, B., Morin, S., Milhe-Poutingon, M., Foucault, P., Chalvin, S., Gelber, C., Baldoni-Andrey, P., Gurieff, N., Fortin, C., & Le Faucheur, S. (2024). New sensitive tools to characterize meta-metabolome response to short- and long-term cobalt exposure in dynamic river biofilm communities. Sci Total Environ, 927, 171851. https://doi.org/10.1016/j.scitotenv.2024.171851
21. Dagher, O., Passos-Castilho, A. M., Sareen, V., Labbe, A. C., Barkati, S., Luong, M. L., Rousseau, C., Benedetti, A., Azoulay, L., & Greenaway, C. (2024). Impact of Language Barriers on Outcomes and Experience of COVID-19 Patients Hospitalized in Quebec, Canada, During the First Wave of the Pandemic. J Immigr Minor Health, 26(1), 3-14. https://doi.org/10.1007/s10903-023-01561-7
22. De Marco, C., Mondesert, B., Desjardins, M., & Raymond-Paquin, A. (2024). An Approach to Cardiac Implantable Electronic Device Pocket Infections: From Prevention to Diagnosis and Management. Card Electrophysiol Clin, 16(4), 383-391. https://doi.org/10.1016/j.ccep.2024.06.004
23. De Wals, P., & Desjardins, M. (2023). Influenza vaccines may protect against cardiovascular diseases: The evidence is mounting and should be known by the Canadian public health community. Can Commun Dis Rep, 49(10), 433-438. https://doi.org/10.14745/ccdr.v49i10a04
24. De Wals, P., & Desjardins, M. (2024). Minimal interval for the administration of a pneumococcal polysaccharide vaccine following the administration of a pneumococcal conjugate vaccine. Vaccine, 42(12), 2933-2936. https://doi.org/10.1016/j.vaccine.2024.02.023
25. Deceuninck, G., Brousseau, N., Lefebvre, B., Quach, C., Tapiero, B., Bui, Y. G., Desjardins, M., & De Wals, P. (2024). Effectiveness of the ten- and thirteen-valent pneumococcal conjugate vaccines to prevent serotype 19A invasive pneumococcal disease in Quebec, Canada. A Canadian immunization research network (CIRN) study. Vaccine, 42(26), 126379. https://doi.org/10.1016/j.vaccine.2024.126379
26. Donko, A., Sharapova, S. O., Kabat, J., Ganesan, S., Hauck, F. H., Bergerson, J. R. E., Marois, L., Abbott, J., Moshous, D., Williams, K. W., Campbell, N., Martin, P. L., Lagresle-Peyrou, C., Trojan, T., Kuzmenko, N. B., Deordieva, E. A., Raykina, E. V., Abers, M. S., Abolhassani, H., . . . Hsu, A. P. (2024). Clinical and functional spectrum of RAC2-related immunodeficiency. Blood, 143(15), 1476-1487. https://doi.org/10.1182/blood.2023022098
27. Doyle, C. M., Milwid, R. M., Cox, J., Xia, Y., Lambert, G., Tremblay, C., Otis, J., Boily, M. C., Baril, J. G., Thomas, R., Blais, A. D., Trottier, B., Grace, D., Moore, D. M., Mishra, S., & Maheu-Giroux, M. (2023). Population-level effectiveness of pre-exposure prophylaxis for HIV prevention among men who have sex with men in Montreal (Canada): a modelling study of surveillance and survey data. J Int AIDS Soc, 26(12), e26194. https://doi.org/10.1002/jia2.26194
28. Doyon-Laliberte, K., Aranguren, M., Chagnon-Choquet, J., Batraville, L. A., Dagher, O., Richard, J., Paniconi, M., Routy, J. P., Tremblay, C., Quintal, M. C., Brassard, N., Kaufmann, D. E., Finzi, A., Poudrier, J., & Roger, M. (2023). Excess BAFF May Impact HIV-1-Specific Antibodies and May Promote Polyclonal Responses Including Those from First-Line Marginal Zone B-Cell Populations. Curr Issues Mol Biol, 46(1), 25-43. https://doi.org/10.3390/cimb46010003
29. Dzieciolowska, S., Charest, H., Roy, T., Fafard, J., Carazo, S., Levade, I., Longtin, J., Parkes, L., Beaulac, S. N., Villeneuve, J., Savard, P., Corbeil, J., De Serres, G., & Longtin, Y. (2023). Timing and Predictors of Loss of Infectivity Among Healthcare Workers With Mild Primary and Recurrent COVID-19: A Prospective Observational Cohort Study. Clinical Infectious Diseases, 78(3), 613-624. https://doi.org/10.1093/cid/ciad535
30. Fournelle, D., Mostefai, F., Brunet-Ratnasingham, E., Poujol, R., Grenier, J. C., Galvez, J. H., Pagliuzza, A., Levade, I., Moreira, S., Benlarbi, M., Beaudoin-Bussieres, G., Gendron-Lepage, G., Bourassa, C., Tauzin, A., Grandjean Lapierre, S., Chomont, N., Finzi, A., Kaufmann, D. E., Craig, M., & Hussin, J. G. (2024). Intra-Host Evolution Analyses in an Immunosuppressed Patient Supports SARS-CoV-2 Viral Reservoir Hypothesis. Viruses, 16(3). https://doi.org/10.3390/v16030342
31. Grunebaum, E., Arnold, D. E., Logan, B., Parikh, S., Marsh, R. A., Griffith, L. M., Mallhi, K., Chellapandian, D., Lim, S. S., Deal, C. L., Kapoor, N., Murguia-Favela, L., Falcone, E. L., Prasad, V. K., Touzot, F., Bleesing, J. J., Chandrakasan, S., Heimall, J. R., Bednarski, J. J., . . . Leiding, J. W. (2024). Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A Primary Immune Deficiency Treatment Consortium study. J Allergy Clin Immunol. https://doi.org/10.1016/j.jaci.2024.01.013
32. Haslund-Gourley, B. S., Woloszczuk, K., Hou, J., Connors, J., Cusimano, G., Bell, M., Taramangalam, B., Fourati, S., Mege, N., Bernui, M., Altman, M. C., Krammer, F., van Bakel, H., Ozonoff, A., Ehrlich, L. I. R., Melamed, E., Sesma, A. F., Simon, V., Pulendran, B., . . . Team, I. C. S. (2024). IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition. Nature Communications, 15(1), 404. https://doi.org/10.1038/s41467-023-44211-0
33. Huddart, S., Yadav, V., Sieberts, S. K., Omberg, L., Raberahona, M., Rakotoarivelo, R., Lyimo, I. N., Lweno, O., Christopher, D. J., Nhung, N. V., Theron, G., Worodria, W., Yu, C. Y., Bachman, C. M., Burkot, S., Dewan, P., Kulhare, S., Small, P. M., Cattamanchi, A., . . . Grandjean Lapierre, S. (2024). A dataset of Solicited Cough Sound for Tuberculosis Triage Testing. Sci Data, 11(1), 1149. https://doi.org/10.1038/s41597-024-03972-z
34. Huletsky, A., Loo, V. G., Longtin, Y., Longtin, J., Trottier, S., Tremblay, C. L., Gilca, R., Lavallee, C., Brochu, E., Berube, E., Bastien, M., Bernier, M., Gagnon, M., Frenette, J., Bestman-Smith, J., Deschenes, L., & Bergeron, M. G. (2024). Comparison of rectal swabs and fecal samples for the detection of Clostridioides difficile infections with a new in-house PCR assay. Microbiol Spectr, 12(6), e0022524. https://doi.org/10.1128/spectrum.00225-24
35. Kassam, P., El-Zein, M., Laurie, C., Tota, J. E., Tellier, P. P., Coutlee, F., de Pokomandy, A., & Franco, E. L. (2024). Use of a carrageenan-based gel had no impact on anal HPVs 16 and 18 viral loads in gay, bisexual, and other men who have sex with men. J Med Virol, 96(3), e29562. https://doi.org/10.1002/jmv.29562
36. Kassam, P., El-Zein, M., Tota, J. E., Tellier, P. P., Coutlee, F., de Pokomandy, A., & Franco, E. L. (2024). HPV vaccination and anal HPV infection in gay, bisexual, and other men who have sex with men. Vaccine, 45, 126644. https://doi.org/10.1016/j.vaccine.2024.126644
37. Khayargoli, P., Mayrand, M. H., Niyibizi, J., Audibert, F., Laporte, L., Lacaille, J., Carceller, A. M., Lacroix, J., Comete, E., Coutlee, F., Trottier, H., & Group, H. S. (2024). Association between Human Papillomavirus 16 Viral Load in Pregnancy and Preterm Birth. Viruses, 16(2). https://doi.org/10.3390/v16020298
38. Kimura, M., Rinaldi, M., Kothari, S., Giannella, M., Anjan, S., Natori, Y., Phoompoung, P., Gault, E., Hand, J., D’Asaro, M., Neofytos, D., Mueller, N. J., Kremer, A. E., Rojko, T., Ribnikar, M., Silveira, F. P., Kohl, J., Cano, A., Torre-Cisneros, J., . . . Husain, S. (2024). Invasive aspergillosis in liver transplant recipients in the current era. Am J Transplant. https://doi.org/10.1016/j.ajt.2024.05.016
39. Laurie, C., El-Zein, M., Tota, J. E., Tellier, P. P., Coutlee, F., Burchell, A. N., & Franco, E. L. (2024). Impact of a carrageenan gel on viral load of genital human papillomavirus infections in sexually active women: Findings from the Carrageenan-gel Against Transmission of Cervical Human papillomavirus (CATCH) trial. J Med Virol, 96(4), e29604. https://doi.org/10.1002/jmv.29604
40. Le, A. S., Labbe, A. C., Fourmigue, A., Dvorakova, M., Cox, J., Fortin, C., Martin, I., Grace, D., Hart, T., Moore, D., Lambert, G., & Engage Study, T. (2023). Mycoplasma genitalium infection among gay, bisexual and other men who have sex with men in Montreal, Canada. Can Commun Dis Rep, 49(11-12), 477-486. https://doi.org/10.14745/ccdr.v49i1112a03
41. Lee, C. H., Banoei, M. M., Ansari, M., Cheng, M. P., Lamontagne, F., Griesdale, D., Lasry, D. E., Demir, K., Dhingra, V., Tran, K. C., Lee, T., Burns, K., Sweet, D., Marshall, J., Slutsky, A., Murthy, S., Singer, J., Patrick, D. M., Lee, T. C., . . . *, A. C. I. I. (2024). Using a targeted metabolomics approach to explore differences in ARDS associated with COVID-19 compared to ARDS caused by H1N1 influenza and bacterial pneumonia. Crit Care, 28(1), 63. https://doi.org/10.1186/s13054-024-04843-0
42. Luong, M. L., Nakamachi, Y., Silveira, F. P., Morrissey, C. O., Danziger-Isakov, L., Verschuuren, E. A. M., Wolfe, C. R., Hadjiliadis, D., Chambers, D. C., Patel, J. K., Dellgren, G., So, M., Verleden, G. M., Blumberg, E. A., Vos, R., Perch, M., Holm, A. M., Mueller, N. J., Chaparro, C., & Husain, S. (2024). Management of infectious disease syndromes in thoracic organ transplants and mechanical circulatory device recipients: a Delphi panel. Transpl Infect Dis, e14251. https://doi.org/10.1111/tid.14251
43. Makarenko, I., Minoyan, N., Bordier Hoj, S., Udhesister, S., Martel-Laferriere, V., Jutras-Aswad, D., Larney, S., & Bruneau, J. (2024). Determinants of psychological distress during the COVID-19 pandemic among people who use drugs in Montreal, Canada. Drug Alcohol Rev. https://doi.org/10.1111/dar.13862
44. Marathe, G., Moodie, E. E., Brouillette, M. J., Delaunay, C. L., Cox, J., Cooper, C., Martel-Laferriere, V., Hull, M., Wong, A., Walmsley, S., Klein, M. B., & Canadian Co-Infection, C. (2024). Effect of depressive symptoms on health services utilization in the HIV and hepatitis C co-infected population in Canada. AIDS Care, 1-7. https://doi.org/10.1080/09540121.2024.2432801
45. Marois, L., Le Gal, C., Cros, G., Falcone, E. L., & Chapdelaine, H. (2024). Refractory wound healing and cytopenias treated with a sodium-glucose cotransporter-2 inhibitor in a patient with glucose-6-phosphatase catalytic subunit 3 deficiency. JAAD Case Rep, 49, 22-24. https://doi.org/10.1016/j.jdcr.2024.04.011
46. Marty, C., Adam, J. P., Martel-Laferriere, V., Doucet, S., & Martel, D. (2024). Impact of universal hepatitis B virus (HBV) screening using chemotherapy orders on the HBV reactivation in cancer patients. Support Care Cancer, 32(8), 541. https://doi.org/10.1007/s00520-024-08750-6
47. Mboumba Bouassa, R. S., Giorgini, G., Silvestri, C., Muller, C., Nallabelli, N., Alexandrova, Y., Durand, M., Tremblay, C., El-Far, M., Chartrand-Lefebvre, C., Messier-Peet, M., Margolese, S., Flamand, N., Costiniuk, C. T., Di Marzo, V., & Jenabian, M. A. (2024). Plasma endocannabinoidome and fecal microbiota interplay in people with HIV and subclinical coronary artery disease: Results from the Canadian HIV and Aging Cohort Study. iScience, 27(8), 110456. https://doi.org/10.1016/j.isci.2024.110456
48. Morais, S., Wissing, M. D., Khosrow-Khavar, F., Burchell, A. N., Tellier, P. P., Coutlee, F., Waterboer, T., El-Zein, M., & Franco, E. L. (2024). Serologic response to human papillomavirus genotypes following vaccination: findings from the HITCH cohort study. Infect Dis (Lond), 56(1), 66-72. https://doi.org/10.1080/23744235.2023.2277390
49. Moreira Gabriel, E., Dias, J., Caballero, R. E., Salinas, T. W., Nayrac, M., Filali-Mouhim, A., Chartrand-Lefebvre, C., Routy, J. P., Durand, M., El-Far, M., Tremblay, C., & Ancuta, P. (2024). Novel Immunological Markers of Intestinal Impairment Indicative of HIV-1 Status and/or Subclinical Atherosclerosis. bioRxiv. https://doi.org/10.1101/2024.11.22.624885
50. Nantel, E., Mayrand, M. H., Audibert, F., Niyibizi, J., Brassard, P., Laporte, L., Lacaille, J., Zahreddine, M., Fraser, W., Francoeur, D., Bedard, M. J., Girard, I., Lacroix, J., Carceller, A. M., Coutlee, F., Trottier, H., & Group, H. S. (2024). Association between the Mode of Delivery and Vertical Transmission of Human Papillomavirus. Viruses, 16(2). https://doi.org/10.3390/v16020303
51. Ng, K., Morais, S., Wissing, M. D., Burchell, A. N., Tellier, P. P., Coutlee, F., Waterboer, T., El-Zein, M., & Franco, E. L. (2024). Empirical sample-specific approaches to define HPV16 and HPV18 seropositivity in unvaccinated, young, sexually active women. Microbiol Spectr, 12(6), e0022924. https://doi.org/10.1128/spectrum.00229-24
52. Olawoye, I. B., Waglechner, N., McIntosh, F., Akochy, P. M., Cloutier, N., Grandjean Lapierre, S., Tannir, B., Greenaway, C., Matouk, E., Poirier, L., Levesque, R. C., Boyle, B., Quach, C., Soualhine, H., Batt, J., Behr, M. A., Lee, R. S., & Guthrie, J. L. (2024). Genomic Epidemiology of Mycobacterium abscessus on the Island of Montreal Not Suggestive of Healthcare-associated Person-to-Person Transmission. J Infect Dis. https://doi.org/10.1093/infdis/jiae407
53. Ozonoff, A., Jayavelu, N. D., Liu, S., Melamed, E., Milliren, C. E., Qi, J., Geng, L. N., McComsey, G. A., Cairns, C. B., Baden, L. R., Schaenman, J., Shaw, A. C., Samaha, H., Seyfert-Margolis, V., Krammer, F., Rosen, L. B., Steen, H., Syphurs, C., Dandekar, R., . . . Rouphael, N. (2024). Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study. Nat Commun, 15(1), 216. https://doi.org/10.1038/s41467-023-44090-5
54. Pando, C., Hazel, A., Tsang, L. Y., Razafindrina, K., Andriamiadanarivo, A., Rabetombosoa, R. M., Ambinintsoa, I., Sadananda, G., Small, P. M., Knoblauch, A. M., Rakotosamimanana, N., & Grandjean Lapierre, S. (2023). A social network analysis model approach to understand tuberculosis transmission in remote rural Madagascar. BMC Public Health, 23(1), 1511. https://doi.org/10.1186/s12889-023-16425-w
55. Peled, Y., Ducharme, A., Kittleson, M., Bansal, N., Stehlik, J., Amdani, S., Saeed, D., Cheng, R., Clarke, B., Dobbels, F., Farr, M., Lindenfeld, J., Nikolaidis, L., Patel, J., Acharya, D., Albert, D., Aslam, S., Bertolotti, A., Chan, M., . . . Walsh, J. (2024). International Society for Heart and Lung Transplantation Guidelines for the Evaluation and Care of Cardiac Transplant Candidates-2024. J Heart Lung Transplant. https://doi.org/10.1016/j.healun.2024.05.010
56. Prévost, R., Roy-St-pierre, É., Idir, K., Khodamoradi, A., Provost, F., Martel, D., Sheehan, N. L., Martel-Laferrière, V., & Therrien, R. (2024). Hepatitis C screening in community pharmacies—A feasibility and knowledge transfer study: PHARMA-C [Article]. JAMMI, 9(3), 161-172. https://doi.org/10.3138/jammi-2024-0010
57. Prosty, C., Katergi, K., Nguyen, A., Luo, O. D., Sorin, M., Cherniak, V., Sebag, M., Demir, K., McDonald, E. G., Lee, T. C., & Cheng, M. P. (2024). Risk of infectious adverse events of venetoclax therapy for hematologic malignancies: a systematic review and meta-analysis of RCTs. Blood Adv, 8(4), 857-866. https://doi.org/10.1182/bloodadvances.2023011964
58. Ramani, H., Gosselin, A., Bunet, R., Jenabian, M. A., Sylla, M., Pagliuzza, A., Chartrand-Lefebvre, C., Routy, J. P., Goulet, J. P., Thomas, R., Trottier, B., Martel-Laferriere, V., Fortin, C., Chomont, N., Fromentin, R., Landay, A., Durand, M., Ancuta, P., El-Far, M., & Tremblay, C. (2023). IL-32 Drives the Differentiation of Cardiotropic CD4+ T-Cells Carrying HIV DNA in People Living with HIV. J Infect Dis. https://doi.org/10.1093/infdis/jiad576
59. Rosain, J., Le Voyer, T., Liu, X., Gervais, A., Polivka, L., Cederholm, A., Berteloot, L., Parent, A. V., Pescatore, A., Spinosa, E., Minic, S., Kiszewski, A. E., Tsumura, M., Thibault, C., Esnaola Azcoiti, M., Martinovic, J., Philippot, Q., Khan, T., Marchal, A., . . . Casanova, J. L. (2024). Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases. J Exp Med, 221(11). https://doi.org/10.1084/jem.20231152
60. Sacks-Davis, R., van Santen, D. K., Boyd, A., Young, J., Stewart, A., Doyle, J. S., Rauch, A., Mugglin, C., Klein, M., van der Valk, M., Smit, C., Jarrin, I., Berenguer, J., Lacombe, K., Requena, M. B., Wittkop, L., Leleux, O., Bonnet, F., Salmon, D., . . . In, C. C. (2024). Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010-19: an analysis of data from a consortium of prospective cohort studies. Lancet HIV, 11(2), e106-e116. https://doi.org/10.1016/S2352-3018(23)00267-9
61. Saeed, S., Thomas, T., Dinh, D. A., Moodie, E., Cox, J., Cooper, C., Gill, J., Martel-Laferriere, V., Panagiotoglou, D., Walmsley, S., Wong, A., & Klein, M. B. (2024). Frequent Disengagement and Subsequent Mortality Among People With HIV and Hepatitis C in Canada: A Prospective Cohort Study. Open Forum Infect Dis, 11(5), ofae239. https://doi.org/10.1093/ofid/ofae239
62. Spinner, C. D., Bell, S., Einsele, H., Tremblay, C., Goldman, M., Chagla, Z., Finckh, A., Edwards, C. J., Aurer, I., Launay, O., Casanas, I. C. C., James, S., Dube, S., Borkowska, K., Jah, F., Kandeil, W., Yokota, R. T. C., Artaud, C., Gottenberg, J. E., . . . Magiorkinis, G. (2024). Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals. Adv Ther. https://doi.org/10.1007/s12325-024-03043-0
63. Tan, J. K., Servellita, V., Stryke, D., Kelly, E., Streithorst, J., Sumimoto, N., Foresythe, A., Huh, H. J., Nguyen, J., Oseguera, M., Brazer, N., Tang, J., Ingebrigtsen, D., Fung, B., Reyes, H., Hillberg, M., Chen, A., Guevara, H., Yagi, S., . . . Chiu, C. Y. (2024). Laboratory validation of a clinical metagenomic next-generation sequencing assay for respiratory virus detection and discovery. Nat Commun, 15(1), 9016. https://doi.org/10.1038/s41467-024-51470-y
64. Weitzel, T., Brown, A., Libman, M., Perret, C., Huits, R., Chen, L., Leung, D. T., Leder, K., Connor, B. A., Menendez, M. D., Asgeirsson, H., Schwartz, E., Salvador, F., Malvy, D., Saio, M., Norman, F. F., Amatya, B., Duvignaud, A., Vaughan, S., . . . Chakravarti, A. (2024). Intestinal protozoa in returning travellers: a GeoSentinel analysis from 2007 to 2019. J Travel Med, 31(4). https://doi.org/10.1093/jtm/taae010
65. Wiche Salinas, T. R., Zhang, Y., Gosselin, A., Do Rosario, N. F., El-Far, M., Filali-Mouhim, A., Routy, J. P., Chartrand-Lefebvre, C., Landay, A. L., Durand, M., Tremblay, C. L., Ancuta, P., Canadian, H. I. V., & Aging Cohort, S. (2023). A Blood Immunological Signature of Subclinical Coronary Artery Atherosclerosis in People Living with HIV-1 Receiving Antiretroviral Therapy. bioRxiv. https://doi.org/10.1101/2023.12.15.571922
66. Wiche Salinas, T. R., Zhang, Y., Gosselin, A., Rosario, N. F., El-Far, M., Filali-Mouhim, A., Routy, J. P., Chartrand-Lefebvre, C., Landay, A. L., Durand, M., Tremblay, C. L., Ancuta, P., Canadian, H. I. V., & Aging Cohort, S. (2024). Alterations in Th17 Cells and Non-Classical Monocytes as a Signature of Subclinical Coronary Artery Atherosclerosis during ART-Treated HIV-1 Infection. Cells, 13(2). https://doi.org/10.3390/cells13020157
67. Yero, A., Goulet, J. P., Shi, T., Costiniuk, C. T., Routy, J. P., Tremblay, C., Mboumba Bouassa, R. S., Alexandrova, Y., Pagliuzza, A., Chomont, N., Ancuta, P., & Jenabian, M. A. (2024). Altered memory CCR6(+) Th17-polarised T-cell function and biology in people with HIV under successful antiretroviral therapy and HIV elite controllers. EBioMedicine, 107, 105274. https://doi.org/10.1016/j.ebiom.2024.105274
68. Zimmer, A. J., Tsang, L. Y., Jolicoeur, G., Tannir, B., Batisse, E., Pando, C., Sadananda, G., McKinney, J., Ambinintsoa, I. V., Rabetombosoa, R. M., Knoblauch, A. M., Rakotosamimanana, N., Chartier, R., Diachenko, A., Small, P., & Grandjean Lapierre, S. (2024). Incidence of cough from acute exposure to fine particulate matter (PM2.5) in Madagascar: A pilot study. PLOS Glob Public Health, 4(7), e0003530. https://doi.org/10.1371/journal.pgph.0003530

Pour obtenir les documents
L’accès au texte intégral des documents est restreint au personnel et aux médecins du CHUM en fonction des abonnements de la bibliothèque. Certains documents sont en accès libre sur le web.

Si vous êtes branchés sur le réseau CHUM :
Cliquer sur les liens fournis pour chaque référence pour vérifier la disponibilité du texte intégral.
Pour les articles provenant de PubMed, cliquer préalablement sur le lien suivant pour afficher la disponibilité du document.

Si vous êtes dans un autre établissement et que vous n’arrivez pas à accéder au texte intégral d’un article à partir du lien donné, vérifier auprès de la bibliothèque de votre institution en donnant la référence complète du document.

Avis de non-responsabilité

1. EXCLUSION DE GARANTIES ET LIMITATION DE RESPONSABILITÉ

Le contenu des veilles informationnelles ou stratégiques (ci-après appelée « Veilles ») est mis à votre disposition à titre informatif pour un usage personnel exclusif. Tout usage commercial du contenu des Veilles est strictement interdit.

Tous les éléments, articles, rapports ou toute autre source d’information figurant dans les Veilles, vous sont fournis « tels quels », sans garantie d’aucune sorte. Eu égard aux propos tenus dans les articles et les rapports sélectionnés pour les Veilles, le CHUM n’offre aucune garantie notamment d’exhaustivité, de fiabilité, d’actualité et d’exactitude.Le CHUM ne pourra en aucun cas être tenu responsable envers quiconque de tout dommage quel qu’il soit, même ceux directs, encouru notamment des suites de toute réclamation, action ou poursuite découlant, même directement, de l’utilisation de ces Veilles.

2. RESPONSABILITÉ RELATIVES AUX LIENS

Les Veilles contiennent des liens vers des sites Web créés et mis à jour par des tierces parties. Ces liens sont fournis pour la commodité des utilisateurs seulement. Le CHUM n’endosse et ne garantit, ni explicitement ni implicitement, l’exactitude ou l’intégralité ni du contenu de ces hyperliens ni des opinions qui y sont exprimées.

Le CHUM n’assume aucune responsabilité à l’égard de ces sites Web externes.

3. PROPRIÉTÉ INTELLECTUELLE

Le CHUM prend tous les moyens raisonnables afin de respecter les droits de propriété intellectuelle afférents au contenu des Veilles et aux modalités du prêt entre bibliothèques, émises par l’Université de Montréal. Le contenu des Veilles, incluant la manière dont il est présenté, sont notamment protégés par la Loi sur le droit d’auteur (L.R.C. (1985), ch. C-42).

Le CHUM ne donne aucune garantie et ne fait aucune déclaration à l’effet que le contenu de ces veilles n’enfreint aucun droit d’une autre personne ou entité.

Le téléchargement, la reproduction en un seul exemplaire ou le tirage sur papier des Veilles ne sont autorisés qu’à des fins de sauvegarde et pour un usage privé et non commercial. Tout téléchargement, reproduction, édition, diffusion sur Internet, utilisation à des fins commerciales ou publiques, distribution, publication sur un autre site ou sur quelque autre forme ainsi que toute autre utilisation est strictement interdite, à moins d’être faite dans le respect des règles de propriété intellectuelle applicables.

Publications du service de microbiologie-infectiologie du CHUM

Description

2024

Formations apparentés

Gestion des données

Reproductibilité en recherche

Équité, diversité et inclusion en santé